Study to Reduce Antibiotic prescription in childhood Pneumonia: implementation of a validated decision rule

Recruiting

• Conditions: lower respiratory tract infections; 10004018; pneumonia

• Registration Number: NL-OMON47230
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 900

Inclusion Criteria

children aged 1 month - 5 years (60 months) with fever and signs suspected of pneumonia

Exclusion Criteria

1) comorbidity resulting in higher risk of (complications of) infectious diseases, i.e. cardiac, pulmonary, renal, neurologic disease or immunodeficiency
2)children with obvious single infectious focus (cutaneous, otitis media, rhinitis)
3) children with parents not able to understand or to act on safety-net instructions

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Rate of narrowspectrum antibiotic prescriptions and uneventful recoveries after<br /><br>CAP</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Compliance to the rule; Safetyendpoints</p><br>